View all news

力量公司任命威廉·j·奈特Chief Operating Officer and Brian P. Monahan to Chief Financial Officer

2009年11月9日

马萨诸塞州比勒里卡(Billerica) - (商业资讯) - 11月。2009年9月9日 - 布鲁克公司(NASDAQ:BRKR)今天宣布,其董事会已任命Bill Knight将首席运营官(COO)和Brian Monahan任命为首席财务官(CFO),生效的日期为2月1日st,2010年。目前,比尔·奈特(Bill Knight)担任首席财务官,布莱恩·莫纳汉(Brian Monahan)担任布鲁克公司(Bruker Corporation)的首席会计官。

布鲁克总裁兼首席执行官弗兰克·劳基恩(Frank Laukien)表示:“布鲁克(Bruker)拥有49年的骄傲技术领导史和以客户为中心的产品创新。展望未来,我们认为,持续创新和对卓越运营的持续关注的结合将推动利润率的扩大,资产负债表指标和现金流,以提高股东价值。为了推动我们的卓越运营计划,我们在布鲁克公司创建了首席运营官的新职位。”

He continued: “Today, we are very pleased to announce the promotion of two extremely capable individuals to expanded responsibilities. Over the past five years, Bill Knight has demonstrated strong financial and operational leadership at Bruker, and in his newly-created COO role Bill will lead and fully focus on our operation excellence initiative. Brian Monahan has been a key leader and contributor in our finance organization over the past five years, and we believe he is an excellent choice to succeed Bill as our CFO.”

Biographies

Mr. Knight joined Bruker Corporation as CFO and Treasurer in October 2004. At Bruker, Mr. Knight is also the President of the Bruker Detection business in the United States. Before joining the Company, Mr. Knight served as an operations-focused CFO in several public companies, and was a founder of ATI Technologies, an analytical instruments company, where he had both financial and operational responsibilities. Mr. Knight served as CFO of Anika Therapeutics, Inc., from 2002 to 2004. He served as CFO of Zycos, Inc., a developer of DNA-based therapeutic products, from 2000 to 2002, and as CFO of NMT Medical, Inc., a provider of cardiovascular and neurological medical devices, from 1998 to 2000. Mr. Knight is a Certified Public Accountant and holds a B.B.A. in Accounting from the University of Wisconsin.

莫纳汉(Monahan)先生于2004年4月加入布鲁克公司(Bruker Corporation)担任公司总监,并于2009年3月被任命为首席会计官兼财务副总裁。除了他的公司责任外,莫纳汉(Monahan)先生还曾在布鲁克·多尔托奇(Bruker Daltonics)担任财务和运营职务。自2006年11月以来,他一直担任布鲁克·达尔顿蒂奇(Bruker Daltonics)的执行副总裁,以及2008年7月以来的美洲总经理。2005年1月,他曾担任布鲁克·达尔顿(Bruker Daltonics)财务助理副总裁。在加入公司之前,从2002年到2004年,Monahan先生担任Fisher Scientific International,Inc。的会计和财务报告经理,并从1999年至2002年担任PriceWaterhouseCoopers LLP的审计经理会计师并拥有学士学位来自马萨诸塞大学的会计。

关于布鲁克公司

布鲁克公司is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis. For more information about Bruker Corporation, please visitwww.fatactor.com

警告声明

本新闻稿中包含的任何陈述都不描述历史事实,可能构成前瞻性陈述,因为该术语是在1995年的《私人证券诉讼改革法》中定义的。对于风险和不确定性,可能导致实际未来结果与预期的结果有重大差异未来已经获得或可能获得的产品,不断变化的技术,产品开发和市场接受我们的产品,我们的产品的成本和价格,制造,竞争,依赖协作合作伙伴和关键供应商,资本支出和政府资助政策,变化政府法规,实现经济刺激的预期利益ULUS计划,知识产权权利,诉讼和对外币波动的暴露以及我们在向美国证券交易委员会提交的文件中不时讨论的其他风险因素。这些因素和其他因素在我们向SEC提交的文件中进行了更详细的详细描述,包括但不限于我们在附表14A上的最新代理声明,即截至2008年12月31日的年度表格10-K年度报告,我们最多的最新的关于表格10-Q的季度报告以及我们目前关于8-K表格的报告。除法律要求外,我们明确违反了更新这些前瞻性陈述的任何意图或义务。

Source: Bruker Corporation

布鲁克公司
Stacey Desrochers, +1-978-663-3660, ext. 1115
投资者关系总监
[email protected]

Categories: 新闻发布
View all news